A Study Evaluating a New Radiation Treatment Workflow (NGDS)
Part of paid clinical trials in St Louis, Missouri.
- Sponsor
- Varian, a Siemens Healthineers Company
- Study ID
- NCT07824583
- Status
- Recruiting
Conditions
- Abdominal Cancer
- Liver Cancer, Adult
- Lung Cancer (Diagnosis)
- Pancreatic Cancer
- Thoracic Cancers
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Next Generation Delivery System (NGDS) — DEVICEParticipant will receive a "mock" treatment on the NGDS machine. Participant will complete experience questionnaires.
Study Details
The purpose of this research is to evaluate the "Next Generation Delivery System" (NGDS) and determine if this machine will be more efficient at delivering radiation in shorter treatment time and better patient tolerance, with less breath holding.
Key Dates
- First listed
- Sep 17, 2026
- Start date
- Jul 31, 2026
- Status verified
- Sep 2026
- Primary completion
- Feb 28, 2027
- Completion
- May 31, 2027
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- DEVICE_FEASIBILITY
Arms
- Other: Single Arm - All patients will be treated the same"Mock" treatment on the NGDS machine.
Primary Outcome Measure
To evaluate the feasibility of the mock NGDS DMAT workflow under breath hold conditions. [ Time Frame: From enrollment to end of "mock" treatment of last participant enrolled, assessed up to 6 months ]
Central Contacts
- Jennifer Woo437-991-3496
Locations (2)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Siteman Cancer Center Washington University | St Louis | Missouri | 63108 | Pamela Samson (PRINCIPAL_INVESTIGATOR) |
| University Hospital Cleveland Medical Center | Cleveland | Ohio | 44106 | Lauren Henke (PRINCIPAL_INVESTIGATOR) |
Find similar trials in St Louis, MO
By condition
By specialty
Related Studies
- Integrated Cancer Repository for Cancer ResearchRecruiting · University of Nebraska · Greenwood Village, Colorado
- Tumor Cell and DNA Detection in the Blood, Urine and Bone Marrow of Patients With Solid CancersRecruiting · University of Missouri-Columbia · Columbia, Missouri
- Tumor Cell and DNA Detection in the Blood, Urine, and Bone MarrowRecruiting · University of Missouri-Columbia · Columbia, Missouri
- VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or LymphomaPHASE1/PHASE2 · Recruiting · VM Oncology, LLC · Santa Rosa, California